Welcome to Wasatch BioLabs. Join us in our mission to revolutionize clinical diagnostics.
Wasatch BioLabs (WBL) is an independent biotechnology company with a disruptive approach to diagnostics. We are an R&D and Oxford Nanopore Technologies-certified laboratory that offers DNA and RNA sequencing services to researchers and clinical service providers. WBL offers both standard Oxford Nanopore assay-based sequencing services as well as proprietary WBL targeted sequencing services that expand the capabilities of the nanopore platform.
As pioneers of nanopore sequencing technology, our experts have decades of experience with bioinformatic, genetic, and epigenetic research. Oxford Nanopore sequencing offers an array of benefits over Illumina and other next generation sequencing technologies, including native strand sequencing, real-time analysis, and long to ultra-long reads.
WBL’s team of R&D scientists have developed technologies that broaden the capabilities of the Nanopore platform and enhance the clinical viability of nanopore sequencing. These improvements provide novel solutions for epigenetic researchers and clinical service providers to facilitate the translation of Oxford Nanopore technologies into clinical care. Our experts have years of hands-on experience in transitioning research designs to clinically validated tests for diagnostic use.
WBL’s R&D is led by our VP of Research and Discovery and our VP of Science and Technology with a combined 30+ years of experience with Illumina, Oxford Nanopore, and other DNA sequencing technologies.
VP of Research and Discovery | Board Member | Co-Founder
Tim, an Associate Professor of Cell Biology and Physiology at BYU, leverages the power of epigenetics as a clinically actionable diagnostics tool. His work extends to include common and severe diseases, male fertility, Alzheimer’s, cancer, and forensics. In his lab, Tim discovers potential applications and identifies novel bench top and bioinformatic approaches to accomplish his aims.
VP of Science and Technology | Board Member | Co-Founder
Jonathon, an Associate Professor of Cell Biology and Physiology at BYU, develops innovative genomic and bioinformatic methods for gene expression analysis and variant detection. He studies the molecular genetics of congenital heart defects in his lab. He is a Fulbright Scholar and a BYU Early-Career Teaching Award recipient, having received his MS in Molecular Biology from the University of Colorado Health Science Center and a PhD in Genetics and Developmental Biology from Columbia University.
WBL’s clinical services are overseen by a High Complexity Laboratory Director (HCLD) and a Director of Compliance with a combined 40+ years of experience in CLIA and CAP accredited laboratory sciences. Our experienced clinical laboratory professionals ensure regulatory compliance of WBL’s operations and developing tests.
Director of Compliance | Co-Founder
Ben is a seasoned healthcare director with over 25 years of experience in CLIA and CAP accredited laboratory sciences and clinical infertility treatment. He has extensive expertise as an andrologist, embryologist, and in optimizing workflows to coordinate clinical care. Ben’s contributions to numerous research studies and clinical trials have resulted in over 40 peer-reviewed articles, scientific abstracts, presentations at meeting symposia, and book chapters that emphasize the importance of precision and accuracy in laboratory developed tests.
Lab Director | Board Member | Co-Founder
Ki Aston, an Associate Professor in the School of Medicine at the University of Utah and in Austin, Texas, completed his PhD in somatic cell nuclear transfer and nuclear reprogramming at Utah State University in 2007. He is board certified as a High Complexity Lab Director and serves as director of reproductive labs at both universities.
Parent Company | Investor
Renew BioTechnologies is dedicated to exploring and embracing groundbreaking biotechnologies and intellectual property. With a remarkable knack for capturing market share, Renew excels in leveraging its cutting-edge technologies and spearheads innovation in the field. Renowned for its strategic alliances and sponsored research agreements with leading universities, Renew consistently enjoys a robust pipeline of exciting new biotech projects, propelling the frontiers of scientific progress.
“We are fundamentally committed to helping researchers and clinicians advance genetics and epigenetics by tackling some of the field's biggest challenges.
Not only do we focus on developing innovative technologies with huge potential clinical impacts—we’re also improving how researchers and physicians interact with their service providers. We understand the importance of a customer experience built on trust, transparency, and efficiency. This is what we strive to provide our clients every day.”
CEO | Co-Founder
Speed
We understand that time is of the essence when it comes to medical diagnostics. That’s why we’ve made speed a top priority in every aspect of our operations. With our cutting-edge technologies and streamlined processes, we’re able to deliver accurate results faster than ever before.
Innovation
At Wasatch BioLabs, innovation is not a goal or a milestone—it’s a lifestyle. It’s part of our culture. That’s why we’re constantly pushing the boundaries of what’s possible, developing new and better ways to get the answers you need.
Transparency
We believe that transparency is the foundation of trust. That’s why we’re dedicated to providing open and honest information about every aspect of our services. We believe that transparency leads to better understanding, and better understanding leads to better test results.
321 W 1300 S
Suite 130
Heber City, UT 84032
